Central pontine myelinolysis prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Central pontine myelinolysis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Referenc...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Central pontine myelinolysis}} | {{Central pontine myelinolysis}} | ||
{{CMG}} | |||
==Overview== | |||
==Prevention== | |||
*Gradual, controlled treatment of low sodium levels may reduce the risk of nerve damage in the pons. | |||
*Being aware of how some medications can change sodium levels can prevent these levels from changing too quickly. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 14:10, 28 September 2012
|
Central pontine myelinolysis Microchapters |
|
Differentiating Central pontine myelinolysis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Central pontine myelinolysis prevention On the Web |
|
American Roentgen Ray Society Images of Central pontine myelinolysis prevention |
|
Risk calculators and risk factors for Central pontine myelinolysis prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prevention
- Gradual, controlled treatment of low sodium levels may reduce the risk of nerve damage in the pons.
- Being aware of how some medications can change sodium levels can prevent these levels from changing too quickly.